These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 11766343

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [Abstract] [Full Text] [Related]

  • 24. Treatment of chronic myelogenous leukemia.
    Giralt S, Kantarjian H, Talpaz M.
    Semin Oncol; 1995 Aug; 22(4):396-404. PubMed ID: 7638636
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Hematologic and cytogenetic response to treatment in patients with chronic myeloid leukemia].
    Tóthová E, Fricová M, Stecová N, Kafková A, Mudronová B, Svorcová E, Guman T, Raffac S, Hlebasková M.
    Cas Lek Cesk; 2000 Jul 19; 139(14):437-9. PubMed ID: 11048406
    [Abstract] [Full Text] [Related]

  • 28. [Chronic myeloid leukemia--case report].
    Hentrich M, Stoetzer OJ, Salat C, Ledderose G.
    Dtsch Med Wochenschr; 2002 Dec 06; 127(49):2617. PubMed ID: 12469273
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Therapy of chronic myeloid leukemia with interferon-alpha. A decade of experiences].
    Freund M, Heussner P, Hild F, Nowak R, Grote-Metke A, Diedrich H, Koch O, Otremba B, von Wussow P, Kleine HD, Meran J, Link H, Hinrichs HF, Balleisen L, Fonatsch C, Poliwoda H.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():18-25. PubMed ID: 8692114
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia.
    Mahon FX, Fabères C, Montastruc M, Si-Mour S, Boiron JM, Marit G, Bilhou-Nabera C, Cony-Makhoul P, Pigneux A, Bernard P, Broustet A, Reiffers J.
    Bone Marrow Transplant; 1996 May 12; 17 Suppl 3():S33-7. PubMed ID: 8769698
    [Abstract] [Full Text] [Related]

  • 34. Use of interferon in the treatment of chronic myelogenous leukemia.
    Talpaz M.
    Semin Oncol; 1994 Dec 12; 21(6 Suppl 14):3-7. PubMed ID: 7992097
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ten-year follow-up of a single center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early phase chronic myeloyd leukemia.
    Meloni G, Capria S, Vignetti M, Alimena G, de Fabritiis P, Montefusco E, Mandelli F.
    Haematologica; 2001 Jun 12; 86(6):596-601. PubMed ID: 11418368
    [Abstract] [Full Text] [Related]

  • 37. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
    Li YF, Deng ZK, Xuan HB, Zhu JB, Ding BH, Liu XN, Chen BA.
    Chin Med J (Engl); 2009 Jun 20; 122(12):1413-7. PubMed ID: 19567163
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Chronic myeloid leukemia. What's in the future therapy in Black Africa?].
    Dokekias AE, Malanda F, Mbalawa ChG.
    Tunis Med; 2003 Mar 20; 81(3):172-9. PubMed ID: 12793067
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.